BE729170A - - Google Patents

Info

Publication number
BE729170A
BE729170A BE729170DA BE729170A BE 729170 A BE729170 A BE 729170A BE 729170D A BE729170D A BE 729170DA BE 729170 A BE729170 A BE 729170A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE729170A publication Critical patent/BE729170A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BE729170D 1968-03-02 1969-02-28 BE729170A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1373468 1968-03-02
JP4640568 1968-07-03

Publications (1)

Publication Number Publication Date
BE729170A true BE729170A (en) 1969-08-01

Family

ID=26349560

Family Applications (1)

Application Number Title Priority Date Filing Date
BE729170D BE729170A (en) 1968-03-02 1969-02-28

Country Status (4)

Country Link
BE (1) BE729170A (en)
DE (1) DE1910481A1 (en)
FR (1) FR2003097A1 (en)
NL (1) NL6903138A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2406849A1 (en) * 1973-03-12 1974-09-19 Poli Ind Chimica Spa NICOTIC ACID TRANS-3,3,5-TRIMETHYLCYCLOHEX-1-YL-ESTER, THE METHOD FOR THEIR MANUFACTURING AND THE MEDICINAL PRODUCT CONTAINING THIS ESTER

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1137375B (en) * 1981-04-15 1986-09-10 Lab Farmaco Biolog Crosara S R COMPOUND WITH PERIPHERAL VASODILATOR ACTIVITY USEFUL AS RUBEFACENT, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS BASED ON THAT COMPOUND
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
ES2382009T3 (en) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company N - ((3-Benzyl) -2,2- (bis-phenyl -) - propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN105143203A (en) 2013-04-17 2015-12-09 辉瑞大药厂 N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2406849A1 (en) * 1973-03-12 1974-09-19 Poli Ind Chimica Spa NICOTIC ACID TRANS-3,3,5-TRIMETHYLCYCLOHEX-1-YL-ESTER, THE METHOD FOR THEIR MANUFACTURING AND THE MEDICINAL PRODUCT CONTAINING THIS ESTER
FR2221130A1 (en) * 1973-03-12 1974-10-11 Poli Ind Chimica Spa

Also Published As

Publication number Publication date
FR2003097A1 (en) 1969-11-07
NL6903138A (en) 1969-09-04
DE1910481A1 (en) 1969-10-09

Similar Documents

Publication Publication Date Title
AU1946070A (en)
AU428130B2 (en)
AU2374870A (en)
AU5184069A (en)
AU6168869A (en)
AU6171569A (en)
AU429879B2 (en)
AU416157B2 (en)
AU2581067A (en)
AU4811568A (en)
AU421558B1 (en)
AU4744468A (en)
AU3789668A (en)
AU3224368A (en)
AU2580267A (en)
AR203075Q (en)
AU479393A (en)
BE708888A (en)
AU463027A (en)
AU4503667A (en)
BE709119A (en)
AU479894A (en)
AU4464266A (en)
AU4270368A (en)
AU4224469A (en)